Acasti Pharma, Inc. (ACST) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

And welcome to the ACASTI-Pharma fourth quarter and fiscal year 2022 financial results conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touchtone phone. Withdraw your question. please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Robert Bloom of Lifem Partners. Please go ahead. All right. Thank you very much, MJ, and welcome to Acacia Pharma's fiscal year and 2022 conference call. On the call with us this afternoon is Jan DelVees, President and Chief Executive Officer, Brian Ford, Chief Financial Officer, and Monique Champagne, Vice President of Clinical Affairs. Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please don't hesitate to contact me at 602-889-9700. I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of the Canadian securities laws and forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and the Securities and Exchange Act of 1934. Such forward-looking statements involve known and unknown risks and uncertainties that could cause the actual results to be materially different from those expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, listeners are urged to consider statements labeled with terms, belief, expe...